HOME > VC DEALS > Addition Therapeutics
Deal IconDeal

Addition Therapeutics

Addition Therapeutics raises $100 million

Addition Therapeutics, a South San Francisco, CA-based biotech company focused on genomic medicine, raised $100 million in a Series A fundraising round led by SR One with participation from Pivotal Life Sciences, Abingworth, and others.

More on VC News Daily →


ADVERTISEMENT carta_vcd_page_OCFO

Similar Health deals

The VC Industry's trusted resource

Stay informed on industry shifts, deal trends, and career opportunities in venture capital.

Jobs